Freeline Therapeutics appoints new Chief Medical Officer

The biotechnology company focused on developing curative gene therapies for chronic systemic diseases has announced the appointment of Julie Krop M.D. as Chief Medical Officer (CMO) with effect from 1^st April 2020.

For further information, visit the Freeline Therapeutics website.